Physicians Decry Pseudo-Science of
Physicians Decry Pseudo-Science of Transgenderism,
‘Absurd’ to Say Anyone is Born Into ‘Wrong Body’
Normalizing Gender Dysphoria is Dangerous and Unethical
August 3, 2016
Gender Dysphoria in Children , In its updated statementthe American College of Pediatricians (College) calls for an end to the normalization of gender dysphoria (GD) in children because it has led to the ongoing experimentation upon, and sterilization of, confused children. Children with GD believe that they are something other than their biological sex. For children experiencing GD before the age of puberty, the confusion resolves over 80 percent of the time by late adolescence. There is a suppressed debate among professionals regarding the new treatment “standard” for childhood GD. This media-popularized standard involves the use of medicines that block puberty followed by life-long use of toxic cross-sex hormones—a combination that results in the sterilization of minors and other significant health risks. A review of current medical literature finds this approach to be rooted in an unscientific gender ideology that violates the long-standing medical ethics principle of “First do no harm.”
Mandates by public institutions to force the acceptance of GD as a normal variant of child development and require social accommodation, toxic hormone therapy and surgical removal of healthy body parts, are misguided and dangerous. The Association of American Physicians and Surgeons, the Christian Medical Association, and the Catholic Medical Association share the College’s concern over this approach. Together our groups represent over 20,000 physicians and health professionals. Opposition also exists among liberal-leaning healthcare professionals who have created an online community known as Youth Trans Critical Professionals. However, those who dare to speak out in support of “First do no harm” often encounter significant public and private harassment, and many have lost or will lose their jobs.
Dr. Michelle Cretella, President of the College states, “We live at a time in which social agendas often bias the results of research and lead to the development of false medical standards. Those who honorably speak out against this are chastised. Young children are being permanently sterilized and surgically maimed under the guise of treating a condition that would otherwise resolve in over 80% of them. This is criminal
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
ALINA Residences: A New Victory in Luxury Living ALINA Residences, located in the heart of Boca Raton, recently snagged the spotlight with its shiny new VERIFIED™ Luxury Residences plaque from Forbes Travel Guide. To most, it might just seem like a piece of metal, but in the world of upscale living, this is a badge of honor. Celebrating Commitment to Service Excellence...
Continue Reading
Staggering Growth in Loan Originations Ever wake up to an unexpected windfall? That's the kind of headline PenFed Credit Union is writing with its $8.8 billion in year-to-date loan originations by the end of September 2026. Up 22% year-over-year, folks. Those numbers don't just happen by accident. That's hitting the nail on the head in the credit union world. Mortgage and...
Continue Reading
Aurora's Rough Road: Production Delays Unveiled You could almost hear the collective groan from investors when Aurora Innovation dropped the bombshell about its truck production delays. You know, after the cheery faces at the Q3 financial results reveal gave way to a rather grim reality check—driverless trucking ain't rolling out quite as planned thanks to those pesky...
Continue Reading
Rough Waters at Alignment Healthcare Not every day we hear about a company sinking its own ship over bookkeeping shenanigans, but here we are. Alignment Healthcare, sitting on Nasdaq under ticker ALHC, is facing the kind of scrutiny that sends shivers down a boardroom's spine. Yeah, Kahn Swick & Foti—those big hitters in securities litigation—have launched an...
Continue Reading
A New Dimension to Halloween's Visuals You ever notice how some TVs just can’t do justice to a Halloween flick? It’s all about the details—those rich, spooky colors and the perfectly balanced light and shadow. The nuance in the shadowy folds of a cape or the eerie glow of a lantern is crucial. Hisense's RGB MiniLED technology is showing up just in time to rescue...
Continue Reading
STARMUS VIII: Where Science and Art Collide Think about this: you're basking in the Canary Islands' sun, surrounded by Nobel laureates and astronauts while the riffs of Queen's Sir Brian May soar in the air. That's exactly what went down at STARMUS VIII, a week-long celebration of science and art held in Tenerife and La Palma from October 17 to 22, 2026. A jamboree of...
Continue Reading
A Family Legacy Transitions in Virginia The trucking world doesn't stop spinning, and Highway Motors, an International dealer rooted deep in Virginia's soil since 1929, knows this intimately. This isn't just a back-of-the-napkin sale; it's a strategic move sweeping through the Interstate 81 corridor, touching Winchester, Harrisonburg, Roanoke, and Leesburg locales. What...
Continue Reading
Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...
Continue Reading
FDA Decision: A Big Win for Reynolds American Boy, am I seeing a shift in the winds. The FDA's green light for VELO nicotine pouches adds a fresh feather to Reynolds American's cap. In a gritty industry like tobacco, getting FDA's nod ain't just about safety; it’s a strategic leg up against traditional smoke. My gut tells me this isn't just about keeping pace. It's...
Continue Reading
Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...
Continue Reading
Top 5 Most Recently Viewed Articles
ImmunityBio's Battle Unfolds: What's at Stake? Twist and turns in the biotech corner never cease to amaze, and ImmunityBio (NASDAQ: IBRX) is the latest firing gun in the securities saloon. Just when you thought the FDA was done dishing out surprises, they smacked ImmunityBio hard, sparking a securities class action lawsuit on a sleepy May afternoon. If you're holding...
Continue Reading
Investors Keep an Eye on Charles Schwab and J.B. Hunt Transport As the U.S. stock market opens, there's a noticeable buzz around a few stocks that are expected to make headlines today. Notably, Charles Schwab Corp. (NYSE: SCHW) is among them, with analysts anticipating an earnings report that reveals quarterly earnings at $1.25 per share, with projected revenue of $5.99...
Continue Reading
Create Stunning Holiday Designs with Appy Pie As the holiday season approaches, many look for innovative ways to express their festive spirit. Appy Pie Design provides a remarkable no-code AI design platform that simplifies the creation of Christmas posters and avatars. This accessible tool empowers both businesses and individuals to effortlessly develop captivating...
Continue Reading
Wearable Devices Announces Successful Funding Initiative Yokneam Illit, Israel – In a significant milestone, Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW), renowned for their groundbreaking artificial intelligence (AI) technology that powers touchless sensing wearables, has successfully initiated a securities purchase agreement. This agreement involves the sale of 670,000...
Continue Reading
Century Communities Plans Fourth Quarter Earnings Call Century Communities, Inc. (NYSE: CCS), a prominent national homebuilder, has officially announced the schedule for its fourth quarter and full year 2025 earnings release. This important financial announcement will take place after market close on January 28, 2026. On the same day, the Company will conduct a conference...
Continue Reading